4.4 Review

CD248: Reviewing its Role in Health and Disease

期刊

CURRENT DRUG TARGETS
卷 13, 期 3, 页码 432-439

出版社

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/138945012799424615

关键词

Cancer; endosialin; fibroblast; inflammation; pericytes; stromal cells

资金

  1. Michael Smith Foundation for Health Research Biomedical Research / Crohns' and Colitis Foundation of Canada
  2. Canadian Institutes for Health Research (CIHR)
  3. Canada Foundations for Innovation

向作者/读者索取更多资源

CD248, also known as endosialin or tumor endothelial marker-1 (TEM-1), is a C-type lectin-like domain (CTLD) containing cell surface glycoprotein that is expressed by stromal cells of proliferating tissues during embryogenesis and postnatally in tumors and inflammatory lesions. Loss-of-function studies in mice support the notion that CD248 promotes tumor growth and inflammation, observations that are stimulating interest in evaluating this molecule as a therapeutic target. In spite of these advances, the mechanisms by which CD248 modulates cancer and inflammation remain largely enigmatic. This review highlights our current understanding of CD248, its structure, pattern of expression, regulation and function in various disease processes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据